Ocuphire Pharma Results

Ocuphire APX3330: Paradigm Shift Oral Treatment Option Presented by: David Lally, MD NEW ENGLAND RETINA CONSULTANTS David Lally, MD Jefferson Medical College ● ● ● ● Director of the Retina Research Institute at New England Retina Consultants Retina Surgeon at Baystate Medical Center Assistant Professor of Ophthalmology at the University of Massachusetts Medical School-Baystate Published in over 25 peer-reviewed ophthalmic journals and delivered over 25 presentations at national meetings Active member of the American Society of Retina Specialists with the Fellow of the American Society of Retina Specialist (FASRS) award designation 31

View entire presentation